Dr Kathy Flitcroft

Honorary Associate
Public Health, School of Public Health

Telephone +61 2 9818 8222

Map

Biographical details

Kathy Flitcroft PhD MA BBSc Grad Cert Health Policy

Research Affiliate Sydney School of Public Health

Research interests

My main research interest is health policy, particularly how evidence is used to inform policy and practice. My PhD was on the role of evidence in bowel cancer screening in Australia, New Zealand and the UK.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Flitcroft, K., Gillespie, J., Carter, S., Salkeld, G., Trevena, L. (2014). Incorporating evidence and politics in health policy: can institutionalising evidence review make a difference? Evidence and Policy, 10(3), 439-455. [More Information]
  • Wong, A., Snook, K., Brennan, M., Flitcroft, K., Tucker, M., Hiercz, D., Spillane, A. (2014). Increasing breast reconstruction rates by offering more women a choice. ANZ Journal of Surgery, 84(1-2), 31-36. [More Information]
  • Flitcroft, K., Spillane, A., Read, R. (2014). Lack of appropriate imaging before breast augmentation can have serious patient consequences. Medical Journal of Australia, 200(4), 198-199. [More Information]
  • Flitcroft, K., Irwig, L., Carter, S., Salkeld, G., Gillespie, J. (2012). Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option. BMC Gastroenterology, 12(December), 1-6. [More Information]
  • Flitcroft, K., St John, D., Howard, K., Carter, S., Pignone, M., Salkeld, G., Trevena, L. (2011). A comparative case study of bowel cancer screening in the UK and Australia: evidence lost in translation? Journal of Medical Screening, 18(4), 193-203. [More Information]
  • Pignone, M., Flitcroft, K., Howard, K., Trevena, L., Salkeld, G., St John, D. (2011). Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia. Medical Journal of Australia, 194(4), 180-185. [More Information]
  • Flitcroft, K., Gillespie, J., Salkeld, G., Carter, S., Trevena, L. (2011). Getting Evidence into Policy: The Need for Deliberative Strategies? Social Science and Medicine, 72, 1039-1046. [More Information]
  • Flitcroft, K., Gillespie, J., Carter, S., Trevena, L., Salkeld, G. (2011). When good evidence is not enough: the role of context in bowel cancer screening policy in New Zealand. Evidence and Policy: a journal of research, debate and practice, 7(3), 307-326. [More Information]
  • Flitcroft, K., Salkeld, G., Gillespie, J., Trevena, L., Irwig, L. (2010). Fifteen years of bowel cancer screening policy in Australia: putting evidence into practice? Medical Journal of Australia, 193(1), 37-42. [More Information]
  • Entwistle, V., Carter, S., Trevena, L., Flitcroft, K., Irwig, L., McCaffery, K., Salkeld, G. (2008). Communicating about screening. BMJ: British Medical Journal, 337(7673), a1591-789-a1591-791. [More Information]
  • Boxall, A., Flitcroft, K. (2007). From little things, big things grow: a local approach to system-wide maternity services reform in the absence of definitive evidence. Australia and New Zealand Health Policy, 4(18), 1-6. [More Information]

2014

  • Flitcroft, K., Gillespie, J., Carter, S., Salkeld, G., Trevena, L. (2014). Incorporating evidence and politics in health policy: can institutionalising evidence review make a difference? Evidence and Policy, 10(3), 439-455. [More Information]
  • Wong, A., Snook, K., Brennan, M., Flitcroft, K., Tucker, M., Hiercz, D., Spillane, A. (2014). Increasing breast reconstruction rates by offering more women a choice. ANZ Journal of Surgery, 84(1-2), 31-36. [More Information]
  • Flitcroft, K., Spillane, A., Read, R. (2014). Lack of appropriate imaging before breast augmentation can have serious patient consequences. Medical Journal of Australia, 200(4), 198-199. [More Information]

2012

  • Flitcroft, K., Irwig, L., Carter, S., Salkeld, G., Gillespie, J. (2012). Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option. BMC Gastroenterology, 12(December), 1-6. [More Information]

2011

  • Flitcroft, K., St John, D., Howard, K., Carter, S., Pignone, M., Salkeld, G., Trevena, L. (2011). A comparative case study of bowel cancer screening in the UK and Australia: evidence lost in translation? Journal of Medical Screening, 18(4), 193-203. [More Information]
  • Pignone, M., Flitcroft, K., Howard, K., Trevena, L., Salkeld, G., St John, D. (2011). Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia. Medical Journal of Australia, 194(4), 180-185. [More Information]
  • Flitcroft, K., Gillespie, J., Salkeld, G., Carter, S., Trevena, L. (2011). Getting Evidence into Policy: The Need for Deliberative Strategies? Social Science and Medicine, 72, 1039-1046. [More Information]
  • Flitcroft, K., Gillespie, J., Carter, S., Trevena, L., Salkeld, G. (2011). When good evidence is not enough: the role of context in bowel cancer screening policy in New Zealand. Evidence and Policy: a journal of research, debate and practice, 7(3), 307-326. [More Information]

2010

  • Flitcroft, K., Salkeld, G., Gillespie, J., Trevena, L., Irwig, L. (2010). Fifteen years of bowel cancer screening policy in Australia: putting evidence into practice? Medical Journal of Australia, 193(1), 37-42. [More Information]

2008

  • Entwistle, V., Carter, S., Trevena, L., Flitcroft, K., Irwig, L., McCaffery, K., Salkeld, G. (2008). Communicating about screening. BMJ: British Medical Journal, 337(7673), a1591-789-a1591-791. [More Information]

2007

  • Boxall, A., Flitcroft, K. (2007). From little things, big things grow: a local approach to system-wide maternity services reform in the absence of definitive evidence. Australia and New Zealand Health Policy, 4(18), 1-6. [More Information]

To update your profile click here. For support on your academic profile contact .